Created at 6:42 p.m. Aug, 20, 2025
Author: arh767
Related Note: 1488768055086 1
Rationale for change

UpToDate, AMBOSS (link: https://next.amboss.com/us/article/vr0AQh?q=heparin-induced+thrombocytopenia#Z2e7fdc780ec989a1c20162108cc5e7f9) and UWorld (QID: 6993) all state that for acute treatment of HIT, either direct thrombin inhibitors or fondaparinux are used. This is a misleading card because it does not include both options and in addition does not specify whether management is acute or empiric (because oral factor Xa inhibitors are the first line oral therapy in clinically stable patients) and may lead to confusion when it comes time to answer questions about this on Step 2. This should either be changed or untagged for the shelf.
Source: Other - UpToDate (https://www-uptodate-com.proxy.lib.wayne.edu/contents/management-of-heparin-induced-thrombocytopenia?search=heparin%20induced%20thrombocytopenia&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H3800006617)

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::02_Heparin #AK_Step2_v12::#CMS::Surgery::Form_06 #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::04_Direct_Acting_Oral_Anticoagulants_(DOACs)_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::04_Direct_coagulation_factor_inhibitors::*Direct_Thrombin_Inhibitors #AK_Step1_v12::#USMLERx::3462.12 #AK_Step2_v12::#AMBOSS #AK_Other::AnKing_Image::!Subjects::Hematology_&_Oncology::Heparin_Induced_Thrombocytopenia #AK_Other::AnKing_Image::!Subjects::Hematology_&_Oncology #AK_Step2_v12::#AMBOSS::uT0ps2 #AK_Step2_v12::Original_decks::Dorian::surg::emma #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::!Shelf::Surgery::no_dupes #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::09_Thrombocytopenia #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::03_Heparin_(MOA,_Indications,_ADR,_CI) #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#UWorld::COMLEX::24189 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::thrombocytopenia #AK_Step2_v12::#Resources_by_rotation::Surgery::emma #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::AnKing_Image::AhmedA::Heparin_Induced_Thrombocytopenia #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::#UWorld::Step::2250 #AK_Step1_v12::#AMBOSS::z4arNk #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::23_Pharmacology_Of_Hemostasis_and_Thrombosis #AK_Step3_v12::#UWorld::5293 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::02_DirectThrombinInhibitors_DirectFactorXaInhibitors #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::thrombocytopenia #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::04_Direct_Thrombin_Inhibitors_(Argatroban/Dabigatran/Bivalirudin) #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::17_Hypercoagulable_States #AK_Step2_v12::#AMBOSS::Bx0zAR #AK_Step2_v12::#CMS::IM::Form_04 #AK_Step2_v12::#FirstAid::07_Hematology::02_Hypercoagulable_States::03_Heparin-Induced_Thrombocytopenia_(HIT) #AK_Step2_v12::#UWorld::COMLEX::28068 #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::19_Platelet_Disorders #AK_Step1_v12::#UWorld::Step::1078 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#AMBOSS::7T04H2 #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Thrombocytopenia